We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Schering-Plough Files European Application for Psychiatric Drug
Schering-Plough Files European Application for Psychiatric Drug
June 2, 2009
The European Medicines Agency has accepted Schering-Plough’s marketing authorization application for Sycrest to treat schizophrenia and manic episodes associated with bipolar I disorder.